
Kimberly-Clark (KMB) Stock Forecast & Price Target
Kimberly-Clark (KMB) Analyst Ratings
Bulls say
Kimberly-Clark is positioned favorably within the tissue and hygiene market, deriving over half of its sales from personal care products and more than one-third from consumer tissue items, underpinned by a strong brand portfolio that includes industry leaders like Huggies and Kleenex. The company plans to enhance its product offering by integrating Kenvue's consumer health portfolio in the second half of 2026, aiming to diversify its revenue channels. Additionally, Kimberly-Clark is committed to innovation, with a robust pipeline anticipated for 2026, which could enable it to leverage advancements in technology and maintain competitive advantages despite competitive pressures in the diaper category.
Bears say
Kimberly-Clark is experiencing a significant decline in organic sales, with projections indicating a -4.0% decrease in North America for the third quarter of 2025, marking a shift from a previous estimate of +4.5%. Additionally, the company has reported a -2.7% decrease in measured retail sales in the U.S. for the third quarter of 2025 to date. Consequently, the firm's earnings per share (EPS) estimates have been revised downward for fiscal year 2025 from $7.60 to $7.41, and for 2026 from $8.00 to $7.85, reflecting growing concerns about its financial performance.
This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.
Kimberly-Clark (KMB) Analyst Forecast & Price Prediction
Start investing in Kimberly-Clark (KMB)
Order type
Buy in
Order amount
Est. shares
0 shares